MyFinsight
Home
Blog
About
Contact
Download
Download image
Impairment of goodwill and
intangible assets
$149,083K
Proceeds from issuance of
common stock
$1,179K
Depreciation and
amortization
$14,002K
Accounts receivable
-$7,818K
Stock-based compensation
$6,362K
Loss on assets held
for sale
$6,269K
Deferred revenue
$3,946K
Inventories
-$3,029K
Inventory write-downs and
other asset...
$2,188K
Deferred income taxes
$490K
Accrued restructuring
costs
$257K
Accrued warranty and
retrofit costs
$126K
Loss (gain) on
disposals of property,...
-$61K
Net cash provided by
operating activities
$13,513K
Net cash used in
financing activities
$980K
Canceled cashflow
$180,118K
Canceled cashflow
$199K
Net decrease in
cash, cash...
-$102,698K
Canceled cashflow
$14,493K
Sales and maturities
of marketable...
$123,814K
Net loss
-$160,798K
Accounts payable
-$8,952K
Other assets and
liabilities
$5,115K
Non-cash gain from
settlement of preexisting...
$3,858K
Accrued compensation
and tax...
-$1,087K
Amortization and accretion on
marketable securities
$308K
Payments of finance
leases
$197K
Withholding tax payments on
net share...
$2K
Net cash used in
investing activities
-$114,749K
Canceled cashflow
$123,814K
Effects of exchange rate
changes on cash, cash...
-$2,442K
Purchases of marketable
securities
$220,143K
Acquisition of uk biocentre,
net of cash acquired
$11,017K
Purchases of property,
plant and equipment
$7,403K
Back
Back
Cash Flow
source: myfinsight.com
Azenta, Inc. (AZTA)
Azenta, Inc. (AZTA)